国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2011年
2期
187-191
,共5页
崔修德%李军%荆凤娥%刘鹏%刘有才%王小燕
崔脩德%李軍%荊鳳娥%劉鵬%劉有纔%王小燕
최수덕%리군%형봉아%류붕%류유재%왕소연
右旋美托咪啶%麻醉%肥胖
右鏇美託咪啶%痳醉%肥胖
우선미탁미정%마취%비반
Dexmedetomidine%Anesthsia%Obesity
目的 比较右旋美托咪啶和瑞芬太尼全凭静脉麻醉对乳腺癌改良根治术肥胖患者循环功能、麻醉镇痛药物、麻醉恢复和不良反应的影响.方法 56例ASAⅠ~Ⅱ级择期全麻下行乳腺癌改良根治术的肥胖病人(34~60岁)纳入此次前瞻、随机、双肓临床研究.患者随机分配入右旋美托咪啶组或瑞芬太尼组,每组28例.右旋美托咪啶组麻酢诱导前给予负荷量1μg/kg(15 min内),继而以0.2~1μg/(kg·h)持续输注;瑞芬太尼组给予负荷量1 μg/kg(15min内),继而以0.05~1 μg/(kg·min)持续输注.配伍丙泊酚和肌松药维持全麻.记录术中血流动力学变化、麻醉镇痛药物的使用量,观察麻醉恢复时间及术后不良反应的发生率.结果 两组患者平均动脉压比较差异无显著性(P>0.05);但瑞芬太尼组拔管时心率明显增快,差异有显著性(P<0.05).右旋美托咪啶组丙泊酚的诱导和维持剂量减少,术毕追加镇痛药的时间延长,术后呼吸抑制、恶心呕吐和寒战的发生率降低,与瑞芬太尼组比较差异有显著性(P<0.05),但麻醉苏醒时间的各项指标延长(P<0.05).两组心动过缓的发生率差异无显著性(P>0.05).结论 右旋美托咪啶全凭静脉麻醉能为肥胖患者乳腺癌手术提供比较平稳的血流动力学,同时减少丙泊酚的使用量,延长追加镇痛药的时间,减少不良反应,但麻醉苏醒时间延长.
目的 比較右鏇美託咪啶和瑞芬太尼全憑靜脈痳醉對乳腺癌改良根治術肥胖患者循環功能、痳醉鎮痛藥物、痳醉恢複和不良反應的影響.方法 56例ASAⅠ~Ⅱ級擇期全痳下行乳腺癌改良根治術的肥胖病人(34~60歲)納入此次前瞻、隨機、雙肓臨床研究.患者隨機分配入右鏇美託咪啶組或瑞芬太尼組,每組28例.右鏇美託咪啶組痳酢誘導前給予負荷量1μg/kg(15 min內),繼而以0.2~1μg/(kg·h)持續輸註;瑞芬太尼組給予負荷量1 μg/kg(15min內),繼而以0.05~1 μg/(kg·min)持續輸註.配伍丙泊酚和肌鬆藥維持全痳.記錄術中血流動力學變化、痳醉鎮痛藥物的使用量,觀察痳醉恢複時間及術後不良反應的髮生率.結果 兩組患者平均動脈壓比較差異無顯著性(P>0.05);但瑞芬太尼組拔管時心率明顯增快,差異有顯著性(P<0.05).右鏇美託咪啶組丙泊酚的誘導和維持劑量減少,術畢追加鎮痛藥的時間延長,術後呼吸抑製、噁心嘔吐和寒戰的髮生率降低,與瑞芬太尼組比較差異有顯著性(P<0.05),但痳醉囌醒時間的各項指標延長(P<0.05).兩組心動過緩的髮生率差異無顯著性(P>0.05).結論 右鏇美託咪啶全憑靜脈痳醉能為肥胖患者乳腺癌手術提供比較平穩的血流動力學,同時減少丙泊酚的使用量,延長追加鎮痛藥的時間,減少不良反應,但痳醉囌醒時間延長.
목적 비교우선미탁미정화서분태니전빙정맥마취대유선암개량근치술비반환자순배공능、마취진통약물、마취회복화불량반응적영향.방법 56례ASAⅠ~Ⅱ급택기전마하행유선암개량근치술적비반병인(34~60세)납입차차전첨、수궤、쌍황림상연구.환자수궤분배입우선미탁미정조혹서분태니조,매조28례.우선미탁미정조마작유도전급여부하량1μg/kg(15 min내),계이이0.2~1μg/(kg·h)지속수주;서분태니조급여부하량1 μg/kg(15min내),계이이0.05~1 μg/(kg·min)지속수주.배오병박분화기송약유지전마.기록술중혈류동역학변화、마취진통약물적사용량,관찰마취회복시간급술후불량반응적발생솔.결과 량조환자평균동맥압비교차이무현저성(P>0.05);단서분태니조발관시심솔명현증쾌,차이유현저성(P<0.05).우선미탁미정조병박분적유도화유지제량감소,술필추가진통약적시간연장,술후호흡억제、악심구토화한전적발생솔강저,여서분태니조비교차이유현저성(P<0.05),단마취소성시간적각항지표연장(P<0.05).량조심동과완적발생솔차이무현저성(P>0.05).결론 우선미탁미정전빙정맥마취능위비반환자유선암수술제공비교평은적혈류동역학,동시감소병박분적사용량,연장추가진통약적시간,감소불량반응,단마취소성시간연장.
Objective To compare the impact on the circulation function and anesthetic recovery between the obese perioperative patients with elective modi?ed radical mastectomy received dexmedetomidine total intravenous anaesthesia and the ones received remifentanil total intravenous anaesthesia; and to explore the anti-pain effect and side-effects of the two group patients. Methods In this prospective randomized double-blind study, 56 cases ASA Ⅰ~Ⅱ and age 34 ~ 60yr morbidly obese patients who were scheduled for modi?ed radical mastectomy, were allocated into two groups averagely.Dexmedetomidine group received i.v. dexmedetomidine 1 μ g/kg as preinduction within 15 minutes, then muscular to maintain anaesthesia. Record hemodynamics changes and anaesthesia drug dose during the operation. Record the anaesthetic recovery time, and observe the postoperative adverse reaction. Results Propofol-remifentanil and propofol-dexmedetomidine got similar intraoperative hemodynamic responses;the mean arterial pressure was similar in the two groups(P>0.05), but heart rate was higher after extubation in remifentanil group (P< 0.05). Propofol doses for induction and maintenance of anesthesia was lower within dexmedetomidine group. The need for earliest analgesic administration was delayed, and the incidence rate of postoperative respiratory depression, nausea, vomiting, shivering were lower in dexmedetomidine group (P<0.05); but the recovery time was longer(P<0.05). Bradycardia was similar between two groups (P> 0.05). Conclusion Dexmedetomidine total intravenous anesthesia provide stable hemodynamics for the morbidly obese patients with elective modi?ed radical mastectomy; and can decrease propofol consumption and undesirable side-effects, delay postoperative analgesics requirement, but it fail to facilitate anesthetic recovery.